These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26586793)

  • 1. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
    Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Moseley PM; Aleskandarany MA; Green AR; Ball G; Alshareeda AT; Rakha EA; Chan SY; Ellis IO; Madhusudan S
    Mol Cancer Ther; 2015 Apr; 14(4):1057-65. PubMed ID: 25673821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.
    Arora A; Parvathaneni S; Aleskandarany MA; Agarwal D; Ali R; Abdel-Fatah T; Green AR; Ball GR; Rakha EA; Ellis IO; Sharma S; Madhusudan S
    Mol Cancer Ther; 2017 Jan; 16(1):239-250. PubMed ID: 27837030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RRM1, TUBB3, TOP2A, CYP19A1, CYP2D6: Difference between mRNA and protein expression in predicting prognosis of breast cancer patients.
    Xu YC; Zhang FC; Li JJ; Dai JQ; Liu Q; Tang L; Ma Y; Xu Q; Lin XL; Fan HB; Wang HX
    Oncol Rep; 2015 Oct; 34(4):1883-94. PubMed ID: 26252353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
    Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
    Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein.
    Alshareeda AT; Negm OH; Aleskandarany MA; Green AR; Nolan C; TigHhe PJ; Madhusudan S; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Aug; 159(1):41-53. PubMed ID: 27464795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional inhibition of RECQL5 helicase elicits non-homologous end joining response and sensitivity of breast cancers to PARP inhibitor.
    Philip KT; Dutta K; Chakraborty S; Patro BS
    Int J Biochem Cell Biol; 2023 Aug; 161():106443. PubMed ID: 37392863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.
    Abdel-Fatah TM; Albarakati N; Bowell L; Agarwal D; Moseley P; Hawkes C; Ball G; Chan S; Ellis IO; Madhusudan S
    Breast Cancer Res Treat; 2013 Dec; 142(3):515-27. PubMed ID: 24253812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer.
    Abdel-Fatah TM; Perry C; Moseley P; Johnson K; Arora A; Chan S; Ellis IO; Madhusudan S
    Breast Cancer Res Treat; 2014 Feb; 143(3):411-21. PubMed ID: 24381055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RECQL5/Recql5 helicase regulates homologous recombination and suppresses tumor formation via disruption of Rad51 presynaptic filaments.
    Hu Y; Raynard S; Sehorn MG; Lu X; Bussen W; Zheng L; Stark JM; Barnes EL; Chi P; Janscak P; Jasin M; Vogel H; Sung P; Luo G
    Genes Dev; 2007 Dec; 21(23):3073-84. PubMed ID: 18003859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
    Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
    Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mining the role of RECQL5 in gastric cancer and seeking potential regulatory network by bioinformatics analysis.
    Lin Y; Chen H; Wang X; Xiang J; Wang H; Peng J
    Exp Mol Pathol; 2020 Aug; 115():104477. PubMed ID: 32497619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
    Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
    Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting RECQL5 Functions, by a Small Molecule, Selectively Kills Breast Cancer
    Chakraborty S; Dutta K; Gupta P; Das A; Das A; Ghosh SK; Patro BS
    J Med Chem; 2021 Feb; 64(3):1524-1544. PubMed ID: 33529023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
    Aleskandarany MA; Agarwal D; Negm OH; Ball G; Elmouna A; Ashankyty I; Nuglozeh E; Fazaludeen MF; Diez-Rodriguez M; Nolan CC; Tighe PJ; Green AR; Ellis IO; Rakha EA
    Breast Cancer Res Treat; 2016 Feb; 156(1):9-20. PubMed ID: 26907764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor RecQL5 controls recombination induced by DNA crosslinking agents.
    Hosono Y; Abe T; Ishiai M; Islam MN; Arakawa H; Wang W; Takeda S; Ishii Y; Takata M; Seki M; Enomoto T
    Biochim Biophys Acta; 2014 May; 1843(5):1002-12. PubMed ID: 24418621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
    Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
    Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients.
    Xu H; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    BMC Cancer; 2018 Jun; 18(1):662. PubMed ID: 29914420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.
    Abdel-Fatah TM; Middleton FK; Arora A; Agarwal D; Chen T; Moseley PM; Perry C; Doherty R; Chan S; Green AR; Rakha E; Ball G; Ellis IO; Curtin NJ; Madhusudan S
    Mol Oncol; 2015 Mar; 9(3):569-85. PubMed ID: 25468710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.